Evaluation of predictive markers of glitazone efficacy in diabetic patients - pilot study

Trial Profile

Evaluation of predictive markers of glitazone efficacy in diabetic patients - pilot study

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2009

At a glance

  • Drugs Rosiglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 28 Jan 2009 Planned patient numbers amended from 30 to 12 as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Actual end date (Jan 2008) added as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top